Renalytix to Present at 42nd Annual William Blair Growth Stock Conference

 

Renalytix to Present at 42nd Annual William Blair Growth Stock Conference

NEW YORK and SALT LAKE CITY, June 08, 2022 (GLOBE NEWSWIRE) — Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the Company will present at the 42nd Annual William Blair Growth Stock Conference on Thursday, June 9 at 2:00 p.m. CT. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at investors.renalytix.com

For further information, please contact:

Renalytix plc www.renalytix.com  
James McCullough, CEO Via Walbrook PR  
     
Stifel (Nominated Adviser, Joint Broker) Tel: 020 7710 7600  
Alex Price / Nicholas Moore    
     
Investec Bank plc (Joint Broker) Tel: 020 7597 4000  
Gary Clarence / Daniel Adams    
     
Walbrook PR Limited Tel: 020 7933 8780 or renalytix@walbrookpr.com  
Paul McManus / Lianne Applegarth / Alice Woodings Mob: 07980 541 893 / 07584 391 303 / 07407 804 654  
     
CapComm Partners Tel: 415-389-6400 or investors@renalytix.com  
Peter DeNardo    

About Renalytix 
Renalytix (NASDAQ: RNLX) (LSE: RENX) is an in-vitro diagnostics and laboratory services company that is the global founder and leader in the new field of bioprognosisTM for kidney health. The leadership team, with a combined 200+ years of healthcare and in-vitro diagnostic experience, has designed its KidneyIntelX laboratory-developed test to enable risk assessment for rapid progressive decline in kidney function in adult patients with T2D with early CKD stages 1-3. We believe that by understanding how disease will progress, patients and providers can take action early to improve outcomes and reduce overall health system costs. For more information, visit www.renalytix.com.

Help Me Spread The Post


If you enjoyed this post, we’d be grateful if you would help us spread its content.


Leave a comment

We’d love to hear your thoughts about this topic or any others. Please leave your comments below.

Note: your email address will not be published.